These findings suggest that USP1 plays a critical role in CCA progression by regulating PARP1 protein levels, and both proteins may serve as independent molecular biomarkers for predicting poor prognosis in CCA patients. This evidence concerns the gene USP1 and cholangiocarcinoma.